Scientists revealed a specific metabolic vulnerability of multiple myeloma cells and identified a targetable axis linking very long chain fatty acid metabolism to the regulation of MET proto-oncogene (MET) and insulin-like growth factor 1 receptor (IGF1R) activity.
[Leukemia]